XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.3
LEASES
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Leases    
LEASES

Note 9. LEASES

 

The Company has one operating lease for its real estate and office space for the CAP/CLIA laboratory, as well as multiple finance leases for lab equipment in Texas that were acquired through the September 18, 2023, acquisition. Additionally, the Company entered into another operating lease on September 1, 2024 with regard to office space. The Company has operating leases consisting of office space with remaining lease terms ranging from 3.1 to 5.9 years as of September 30, 2024. The Company has finance leases consisting of office and lab equipment with remaining lease terms ranging from approximately 1.5 to 3.3 years as of September 30, 2024, for which the Company has determined that it will use the equipment for a major part of its remaining economic life.

 

The lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach as of the date of inception of the leases to derive an appropriate incremental borrowing rate to discount remaining lease payments. The Company benchmarked itself against other companies of similar credit ratings and comparable quality and derived imputed interest rates ranging from 7.43% to 8.07% for the lease term lengths.

 

Leases with an initial term of 12 months or less are not recorded on the balance sheet. There are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space. The Company has not entered into any lease arrangements with related parties, and the Company is not the sublessor in any arrangement.

 

The Company’s existing leases contain escalation clauses and renewal options. The Company has evaluated several factors in assessing whether there is reasonable certainty that the Company will exercise a contractual renewal option. For leases with renewal options that are reasonably certain to be exercised, the Company included the renewal term in the total lease term used in calculating the right-of-use asset and lease liability.

 

 

The components of lease expense, which are included in selling, general and administrative expense and depreciation and amortization for the three and nine months ended September 30, 2024 and 2023, are as follows:

 

   2024   2023   2024   2023 
   Three months ended September 30,   Nine months ended September 30, 
   2024   2023   2024   2023 
Amortization of right-of-use asset - finance lease  $96,243   $32,081   $288,729   $32,081 
Interest on lease liabilities - finance lease   21,533    8,634    67,318    8,634 
Operating lease cost   33,198    9,972    93,029    9,972 
Total lease cost  $150,974   $50,687   $449,076   $50,687 
                     
Cash paid for amounts included in the measurement of lease liabilities:                    
Operating cash flows from finance leases  $(91,038)  $   $(270,143)  $(8,433)
Operating cash flows from operating leases   (203)       (1,235)    

 

Supplemental balance sheet information relating to leases was as follows as of September 30, 2024, and December 31, 2023:

 

Operating leases:  September 30, 2024   December 31, 2023 
Operating lease right-of-use asset  $493,687   $370,312 
Operating lease liability, current  $124,710   $94,708 
Operating lease liability, long-term  $375,139   $283,001 

 

Finance leases:  September 30, 2024   December 31, 2023 
Finance lease right-of-use asset, gross  $1,294,168   $1,294,168 
Accumulated amortization   (417,053)   (128,324)
Finance lease right-of-use asset, net  $877,115   $1,165,844 
Finance lease liability, current portion  $387,780   $365,463 
Finance lease liability, long-term   543,007    835,467 
Total finance lease liabilities  $930,787   $1,200,930 

 

Weighted-average remaining lease term:  September 30, 2024   December 31, 2023 
Operating leases (in years)   4.17    3.58 
Finance leases (in years)   2.60    3.25 

 

Weighted-average discount rate:  September 30, 2024   December 31, 2023 
Operating leases   7.43%   8.07%
Finance leases   8.02%   8.01%

 

Future minimum lease payments under non-cancellable lease as of September 30, 2024, are as follows:

 

   Operating Leases   Finance Leases 
Remaining for 2024  $39,341   $112,126 
2025   157,837    448,505 
2026   159,282    270,395 
2027   110,063    202,970 
2028 and thereafter   111,788     
Total undiscounted cash flows   578,311    1,033,996 
Less discounting   (78,462)   (103,209)
Present value of lease liabilities  $499,849   $930,787 

 

 

 
LEASES  

Note 9. LEASES

 

The Company has one operating lease for its real estate and office space and multiple finance leases for lab equipment in Texas that was acquired through the September 18, 2023, Acquisition. The operating lease has a remaining lease term of 3.58 years as of December 31, 2023. The Company has finance leases consisting of office and lab equipment with remaining lease terms ranging from approximately 2.25 to 4.0 years as of December 31, 2023, for which the Company has determined that it will use the equipment for a major part of its remaining economic life.

 

The lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach as of December 31, 2023, to derive an appropriate incremental borrowing rate to discount remaining lease payments. The Company benchmarked itself against other companies of similar credit ratings and comparable quality and derived imputed interest rates ranging from 7.97% to 8.13% for the lease term lengths.

 

Leases with an initial term of 12 months or less are not recorded on the balance sheet. There are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space. The Company has not entered into any lease arrangements with related parties, and the Company is not the sublessor in any arrangement.

 

The Company’s existing leases contain escalation clauses and renewal options. The Company has evaluated several factors in assessing whether there is reasonable certainty that the Company will exercise a contractual renewal option. For leases with renewal options that are reasonably certain to be exercised, the Company included the renewal term in the total lease term used in calculating the right-of-use asset and lease liability. Prior to adoption of ASU 2016-02 effective January 1, 2022, the Company accounted for operating lease transactions by recording lease expense on a straight-line basis over the expected term of the lease.

 

The components of lease expense, which are included in selling, general and administrative expense and depreciation and amortization for the year ended December 31, 2023, and 2022 are as follows:

 

Components of lease expense:  2023   2022 
Amortization of right-of-use assets - finance lease  $128,324   $ 
Interest on lease liabilities - finance lease   33,838     
Operating lease cost   39,887     
Total lease cost  $202,049   $ 

 

Operating leases:  2023   2022 
Operating lease right-of-use, assets  $370,312   $ 
Operating lease liability, current   94,708     
Operating lease liability, non-current   283,001     
Total operating lease liabilities  $377,709   $ 

 

Financing leases:  2023   2022 
Financing lease right-of-use assets, gross  $1,294,168   $ 
Accumulated amortization   (128,324)     
Finance lease right-of-use assets, net  $1,165,844   $ 
Financing lease liability, current   365,463     
Financing lease liability, non-current   835,467     
Financing lease liability, long-term  $1,200,930   $ 

 

Weighted-average remaining lease term:  2023   2022 
Operating leases (in years)   3.58     
Finance leases (in years)   3.25     

 

Weighted-average discount rate:  2023   2022 
Operating leases   8.07%    
Finance leases   8.01%    

 

   Operating Leases   Finance Leases 
2024  $121,726   $448,505 
2025   121,726    448,505 
2026   121,726    270,395 
2027 and thereafter   71,007    202,970 
Total undiscounted cash flows   436,185    1,370,375 
Less discounting   (58,476)   (169,445)
Present value of lease liabilities  $377,709   $1,200,930